 |
||
 |
|
|
| In February 2003, Cytomics Pharmaceuticals closed a first round of financing with Société Générale Asset Management Alternative Investment (SGAM AI, France). In February 2006, Cytomics Pharmaceuticals closed a second round of financing with Edmond de Rothschild Investment Partners and Truffle Venture as co-leads. SGAM AI also participated in this investment. Cytomics Pharmaceuticals has also been supported by IFSI (incubator), and the company was awarded grants by the French Ministry of Research, ANVAR (a public body supporting industrial innovation) and the European Union.
|
|
|
 |
||||||||
     |
||||||||
|
||||||||
     |
||||||||
